MDT · Medtronic plc.
$82.01
+0.15% last session
End-of-day data · updated 2026-07-25
Market cap
$107B
Enterprise value
$127B
Trailing P/E
22.3
Forward P/E
13.0
Dividend yield
4.0%
Beta
0.58
Avg volume
10M
Employees
95K
2D change
1.46%
5D change
-0.10%
10D change
3.40%
30D change
4.27%
60D change
8.20%
MTD change
5.06%
YTD change
-11.88%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MDT
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-28
Latest call per bank · past 12 months
UBS
Buy$100
+21.9% vs priceGoldman Sachs
Neutral$83.00
+1.2% vs priceRBC Capital
Outperform$118
+43.9% vs priceWells Fargo
Overweight$102
+24.4% vs priceCitigroup
Buy$110
+34.1% vs priceBarclays
Overweight$120
+46.3% vs priceJP Morgan
Neutral$100
+21.9% vs priceMorgan Stanley
Overweight$117
+42.7% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-28 | UBS | Upgrade | Neutral → Buy | $85.00 → $100 |
| 2026-07-10 | TD Cowen | Maintains | Buy | $119 → $100 |
| 2026-07-06 | Evercore ISI Group | Maintains | Outperform | $106 → $105 |
| 2026-06-17 | Needham | Reiterates | Buy | $101 |
| 2026-06-05 | Goldman Sachs | Maintains | Neutral | $84.00 → $83.00 |
| 2026-06-05 | Bernstein | Maintains | Outperform | $112 → $97.00 |
| 2026-06-04 | UBS | Maintains | Neutral | $90.00 → $85.00 |
| 2026-06-04 | TD Cowen | Reiterates | Buy | $119 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 52 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 3.3% above the 50-day MA ($79.36).
- Price vs 200-day MA: Trading 7.9% below the 200-day MA ($89.06).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-0.11) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($73.09) and high ($102.81).
MDT Price Chart
Loading chart for MDT…
Fundamentals
About Medtronic plc.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
More in Medical Devices
ABT
Abbott Laboratories
$180B -16.2% YTD
SYK
Stryker Corporation
$127B -5.5% YTD
BSX
Boston Scientific Corporation
$66B -53.6% YTD
EW
Edwards Lifesciences Corporatio
$48B -3.1% YTD
GEHC
GE HealthCare Technologies Inc.
$28B -26.1% YTD
DXCM
DexCom, Inc.
$28B 7.8% YTD
PHG
Koninklijke Philips N.V. NY Reg
$25B 0.4% YTD
STE
STERIS plc (Ireland)
$21B -15.1% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.